Elevance Health Inc
ELV
View Detailed Chart
306.910USD
-4.850-1.56%
Market hours （ET）Quotes delayed by 15 min
69.00BMarket Cap
12.87P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.56%
5 Days
-2.15%
1 Month
+3.89%
6 Months
-27.09%
Year to Date
-16.80%
1 Year
-44.28%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
24
analysts
Buy
Current Rating
366.228
Target Price
+17.47%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 25.38%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 25.38%.
Undervalued
The company’s latest PE is 13.19, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 215.32M shares, decreasing 2.08% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 22.75M shares of this stock.
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefit, CarelonRx, Carelon Services, and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to Individual, employer group risk-based, employer group fee-based, BlueCard, Medicare, Medicaid and federal employees health benefits (FEHB) program members. The CarelonRx segment includes its pharmacy business. CarelonRx markets and offers pharmacy services to affiliated health plan customers, as well as to external customers outside of the health plans. It also offers infusible and injectable therapies. Carelon Services offers healthcare-related services and capabilities to internal and external customers including integrated care delivery, behavioral health, palliative care, utilization management, payment integrity services and subrogation services, as well as health and wellness programs.
Ticker SymbolELV
CompanyElevance Health Inc
CEOMs. Gail K. Boudreaux
Websitehttps://www.elevancehealth.com/
